Wave Life Sciences, Inc. SEC filings WVE

Wave Life Sciences, Inc. has 743 filings in SEC EDGAR's recent list, going back to Feb 2, 2015. Its latest annual report, Form ARS, was filed on Oct 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.

Wave Life Sciences, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Oct 14, 2026 Nov 12, 2026
DEF 14A Proxy statement May 7, 2026 Jun 22, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
PRE 14A Preliminary proxy statement Apr 15, 2026 Apr 15, 2026
DEFA14A Additional proxy material Apr 15, 2026 —
DEF 14A Proxy statement Jun 23, 2025 Aug 5, 2025
DEF 14A Proxy statement Jun 21, 2024 Aug 6, 2024
DEF 14A Proxy statement Jun 26, 2023 Aug 1, 2023
DEF 14A Proxy statement Jun 29, 2022 Aug 9, 2022
DEF 14A Proxy statement Jun 28, 2021 Aug 10, 2021
DEF 14A Proxy statement Jun 26, 2020 Aug 12, 2020
DEF 14A Proxy statement Jun 26, 2019 Aug 8, 2019
DEF 14A Proxy statement Jun 28, 2018 Aug 7, 2018
DEF 14A Proxy statement Jul 6, 2017 Aug 10, 2017
DEF 14A Proxy statement Jul 15, 2016 Aug 18, 2016

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
WVE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Large accelerated filer
SEC CIK
1631574
Former names
Wave Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences LTD. (until Jul 30, 2026); WAVE Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences Pte Ltd (until Nov 2, 2015)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.